Stay updated on Nivolumab with DA-REPOCH for B-Cell Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab with DA-REPOCH for B-Cell Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab with DA-REPOCH for B-Cell Lymphoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The site revision label changed from v3.7.2 to v3.8.0, while the study record remains unavailable on a 403 error page.
    Difference
    0.2%
    Check dated 2026-10-31T13:34:03.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A site-wide NIH notice appears above the page, announcing a terminology transition from “Artificial Intelligence” to “Super Intelligence” and linking to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T13:19:01.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The site revision indicator changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T13:36:22.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changes from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T13:17:29.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    A 403 Forbidden error is now displayed for the study page, replacing the study content; core metadata and sponsor/investigator information appears to be removed or inaccessible on the page.
    Difference
    25%
    Check dated 2026-09-19T14:28:36.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.5 to v3.6.6, indicating a minor update to the record's version history.
    Difference
    0.0%
    Check dated 2026-08-29T14:05:00.000Z thumbnail image

Stay in the know with updates to Nivolumab with DA-REPOCH for B-Cell Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab with DA-REPOCH for B-Cell Lymphoma Clinical Trial page.